|
Orthologous residues
|
|
VEGFR‑2 (human): Y1175‑p, VEGFR‑2 (mouse): Y1173‑p, VEGFR‑2 (rat): Y1171‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
endothelial, ES (stem)
|
|
Cellular systems studied:
primary cells
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
|
|
VEGFR-1 (mouse)
|
|
increase
|
homozygous null
|
|
